This evidence is supported by epigenome-wide studies (EWAS), which have assessed changes in the whole DNA methylation patterns from peripheral blood mononuclear cells (PBMCs) and CD4+ and CD8+ T cells in MS patients [84,85]. The gene discussed is CD8A; the disease is myeloid sarcoma.